ABEONA THERAPEUTICS (ABEO) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
ABEONA THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 9 sold $3.6M of ABEO stock on the open market.
Get emailed when insiders cluster-buy stocks like ABEO
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ABEO insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1.1M | 10 |
| Q2 2026 | — | 0 | $1.1M | 14 |
| Q1 2026 | — | 0 | $1.2M | 12 |
| Q4 2025 | — | 0 | $205K | 3 |
| Q3 2025 | — | 0 | $334K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 ABEONA THERAPEUTICS INC. insiders reported open-market purchases totaling $0, while 9 insiders reported sales totaling $3.6M. 8 of 43 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ABEO earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 13, 2026 | +23.9% | Sold $10K | -19.7%S&P +0.5% | -9.5% |
| May 13, 2026 | +6.4% | Sold $33K | -1.4%S&P +1.4% | -1.2% |
| Mar 17, 2026 | -3.3% | Sold $4K | -8.1%S&P -1.1% | +20.9% |
| Nov 12, 2025 | -24.7% | Sold $1K | +8.6%S&P -1.6% | +18.3% |
| Aug 14, 2025 | -2.8% | None | +8.7%S&P -0.2% | -9.8% |
| Jul 2, 2025 | -6.7% | None | +5.7%S&P +1.2% | +10.2% |
| May 15, 2025 | +1.7% | None | +13.2%S&P +1.1% | +1.0% |
| Mar 20, 2025 | +2.6% | None | -1.0%S&P -0.3% | -6.0% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 29SEC | Vishwas SeshadriCEO | Sell | 19,6081,286,500 held (−2%) | $5.16 | $101K | -4.3% | — |
| Sep 29SEC | Joseph Walter VazzanoCFO | Sell | 9,191482,888 held (−2%) | $5.16 | $47K | -4.3% | — |
| Sep 29SEC | Brendan M. O'malleyGeneral Counsel | Sell | 6,727421,226 held (−2%) | $5.16 | $35K | -4.3% | — |
| Sep 29SEC | Madhav VasanthavadaChief Commercial Officer | Sell | 4,902285,721 held (−2%) | $5.16 | $25K | -4.3% | — |
| Sep 1SEC | Mark AlvinoDirector | Sell | 15,00062,065 held (−19%) | $5.86 | $88K | -15.7% | — |
| Jul 22SEC | Joseph Walter VazzanoCFO | Sell | 1,478492,079 held (−0%) | $6.53 | $10K | -24.3% | — |
| Jul 9SEC | Vishwas SeshadriCEO | Sell | 67,9711,306,108 held (−5%) | $6.96 | $473K | -29.0% | — |
| Jul 9SEC | Joseph Walter VazzanoCFO | Sell | 24,880493,557 held (−5%) | $6.96 | $173K | -29.0% | — |
| Jul 9SEC | Madhav VasanthavadaChief Commercial Officer | Sell | 12,606290,623 held (−4%) | $6.96 | $88K | -29.0% | — |
| Jul 9SEC | Brendan M. O'malleyGeneral Counsel | Sell | 12,050427,953 held (−3%) | $6.96 | $84K | -29.0% | — |
| Jul 2SEC | Leila AllandDirector | Sell | 11,000162,614 held (−6%) | $5.92 | $65K | -16.6% | — |
| Jun 15SEC | Christine Berni SilversteinDirector | Sell | 18,160119,562 held (−13%) | $5.71 | $104K | -13.5% | — |
| Jun 9SEC | Vishwas SeshadriCEO | Sell | 31,9161,374,079 held (−2%) | $5.30 | $169K | -6.8% | — |
| Jun 9SEC | Joseph Walter VazzanoCFO | Sell Plan | 25,646518,437 held (−5%) | $5.39 | $138K | -8.3% | — |
| Jun 9SEC | Vishwas SeshadriCEO | Sell | 24,4281,405,995 held (−2%) | $5.43 | $133K | -9.0% | — |
| Jun 9SEC | Joseph Walter VazzanoCFO | Sell Plan | 13,421544,083 held (−2%) | $5.30 | $71K | -6.8% | — |
| Jun 9SEC | Joseph Walter VazzanoCFO | Sell Plan | 10,271557,504 held (−2%) | $5.43 | $56K | -9.0% | — |
| Jun 9SEC | Brendan M. O'malleyGeneral Counsel | Sell | 6,305440,003 held (−1%) | $5.30 | $33K | -6.8% | — |
| Jun 9SEC | Madhav VasanthavadaChief Commercial Officer | Sell | 5,450303,451 held (−2%) | $5.30 | $29K | -6.8% | — |
| Jun 9SEC | Brendan M. O'malleyGeneral Counsel | Sell | 4,826446,308 held (−1%) | $5.43 | $26K | -9.0% | — |
| Jun 9SEC | Madhav VasanthavadaChief Commercial Officer | Sell | 4,170308,901 held (−1%) | $5.43 | $23K | -9.0% | — |
| May 22SEC | Mark AlvinoDirector | Sell | 6,50077,565 held (−8%) | $5.46 | $35K | -9.5% | — |
| May 15SEC | Eric CrombezDirector | Sell Plan | 26,14337,313 held (−41%) | $5.53 | $145K | -10.7% | — |
| May 11SEC | Madhav VasanthavadaChief Commercial Officer | Sell | 5,548313,071 held (−2%) | $5.96 | $33K | -17.1% | — |
| Mar 31SEC | Vishwas SeshadriCEO | Sell Plan | 29,9851,430,423 held (−2%) | $4.38 | $131K | +12.8% | — |
| Mar 16SEC | Joseph Walter VazzanoCFO | Sell | 785567,775 held (−0%) | $4.76 | $4K | +3.8% | — |
| Feb 4SEC | Christine Berni SilversteinDirector | Sell | 20,070137,722 held (−13%) | $5.09 | $102K | -2.9% | — |
| Feb 2SEC | Leila AllandDirector | Sell | 18,065173,614 held (−9%) | $5.09 | $92K | -2.9% | — |
| Feb 2SEC | Eric CrombezDirector | Sell | 16,28463,456 held (−20%) | $5.09 | $83K | -2.9% | — |
| Feb 2SEC | Donald A. WuchterlDirector | Sell | 14,814167,935 held (−8%) | $5.09 | $75K | -2.9% | — |
| Feb 2SEC | Mark AlvinoDirector | Sell | 2,00084,065 held (−2%) | $5.09 | $10K | -2.9% | — |
| Jan 26SEC | Madhav VasanthavadaChief Commercial Officer | Sell | 12,610318,619 held (−4%) | $5.29 | $67K | -6.6% | — |
| Jan 22SEC | Vishwas SeshadriCEO | Sell | 69,8321,460,408 held (−5%) | $5.33 | $372K | -7.3% | — |
| Jan 22SEC | Joseph Walter VazzanoCFO | Sell | 18,666568,560 held (−3%) | $5.33 | $99K | -7.3% | — |
| Jan 22SEC | Brendan M. O'malleyGeneral Counsel | Sell | 13,578451,134 held (−3%) | $5.33 | $72K | -7.3% | — |
| Jan 21SEC | Mark AlvinoDirector | Sell | 13,50048,752 held (−22%) | $5.23 | $71K | -5.5% | — |
| Dec 29SEC | Vishwas SeshadriCEO | Sell Plan | 25,0001,164,818 held (−2%) | $5.31 | $133K | -7.0% | — |
| Nov 14SEC | Mark AlvinoDirector | Sell | 15,00062,252 held (−19%) | $4.74 | $71K | +4.2% | — |
| Oct 16SEC | Vishwas SeshadriCEO | Sell | 2491,189,818 held (−0%) | $5.49 | $1K | -10.0% | — |
| Oct 1SEC | Vishwas SeshadriCEO | Sell Plan | 25,0001,190,067 held (−2%) | $5.24 | $131K | -5.7% | — |
| Oct 1SEC | Vishwas SeshadriCEO | Sell Plan | 19,2741,215,067 held (−2%) | $5.39 | $104K | -8.3% | — |
| Oct 1SEC | Brendan M. O'malleyGeneral Counsel | Sell | 9,366350,763 held (−3%) | $5.39 | $50K | -8.3% | — |
| Oct 1SEC | Joseph Walter VazzanoCFO | Sell | 9,035453,631 held (−2%) | $5.39 | $49K | -8.3% | — |
Insiders at ABEONA THERAPEUTICS INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Vishwas SeshadriCEO | — | $1.7M | Sep 29, 2026 | — |
| Joseph Walter VazzanoCFO | — | $647K | Sep 29, 2026 | — |
| Brendan M. O'malleyGeneral Counsel | — | $301K | Sep 29, 2026 | — |
| Mark AlvinoDirector | — | $275K | Sep 1, 2026 | — |
| Madhav VasanthavadaChief Commercial Officer | — | $264K | Sep 29, 2026 | — |
| Eric CrombezDirector | — | $227K | May 15, 2026 | — |
| Christine Berni SilversteinDirector | — | $206K | Jun 15, 2026 | — |
| Leila AllandDirector | — | $157K | Jul 2, 2026 | — |
| Donald A. WuchterlDirector | — | $75K | Feb 2, 2026 | — |
ABEO stock: common questions
Are ABEONA THERAPEUTICS INC. insiders buying ABEO stock?
In the past 12 months, 0 insiders reported open-market purchases of ABEO worth $0.
Are ABEONA THERAPEUTICS INC. insiders selling ABEO stock?
9 insiders reported sales worth $3.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ABEO's 52-week range?
Over the past year ABEO has traded between $4.17 and $7.46. It last closed at $4.94 on Oct 9, 2026.